Condition 1: Chronic ischemic heart disease. Condition 2: ischemic heart disease. Condition 3: Acute myocardial infarction. Condition 4: Subsequent myocardial infarction. Condition 5: acute ischemic heart diseases. Condition 6: heart failure. Condition 7: hypertension. Condition 8: diabetes mellitus. Condition 9: Hyperlipidaemia. Condition 10: cardiac rehabilitation. Chronic ischemic heart disease Angina pectoris ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Subseq
Conditions
Interventions
Intervention 1: Control group: This group includes patients who undergo routine rehabilitation in the hospital. Rehabilitation performed in accordance with the latest available standards, including th
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with heart failure who are candidates for cardiac Rehabilitation Post Coronary Artery Bypass Grafting(CABG) patients who are candidates for cardiac Rehabilitation Post Myocardial infarction(MI) patients who are candidates for cardiac Rehabilitation Patient with ischemic heart disease(IHD) who are candidates for cardiac Rehabilitation
Exclusion criteria
Exclusion criteria: lesion at left main(LM) artery lesion at ostium of Left Circumflex Artery(LCX) Patients who have had life-threatening arrhythmia's in the past month Patients with stage 4 heart failure lesion at left anterior descending artery(LAD) dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients Blood pressure (systolic and diastolic). Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Mercury sphygmomanometer.;Fasting blood sugar. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Automatic chemistry analyzer model "BIOTECNICA BT 3500".;Frequency of smoking. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: questionnaire.;Dyslipidemia. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Automatic chemistry analyzer model "BIOTECNICA BT 3500".;Exercise capacity based on METs. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Exercise test.;Anxiety score in Spielberger questionnaire. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Spielberger questionnaire.;Depression score in Beck questionnaire. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: Beck questionnaire.;"Quality of life" score in the macnew questionnaire. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: macnew questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of myocardial infarction. Timepoint: At the beginning of the study and immediately after the completion of rehabilitation and 6 months after cardiac rehabilitation. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh Sattar
Esfahan University of Medical Sciences
Outcome results
None listed